Several reports have suggested that ERβ has anti-proliferative action in BC cells, by increasing the expression of anti-proliferative genes and/or decreasing the expression of proliferative and anti-apoptotic genes [11-15] and the ERα/ERβ ratio determines the cell-specific response to estrogen. The gene discussed is ESR1; the disease is breast cancer.